issue

Jul 17, 2023

Volume 19 Number 4

In this issue of EuroIntervention, we have a debate on in-hospital PCSK9 inhibitor initiation. In coronary interventions, the effects of alirocumab on coronary haemodynamics as assessed by quantitative flow ratio and percentage diameter stenosis by three-dimensional quantitative coronary angiography; the five-year clinical results of the EBC TWO Trial; posterior pericardiotomy for postoperative atrial fibrillation; a novel IVUS-OCT hybrid; and the NEOMINDSET Trial, SAPT with a potent P2Y12 inhibitor compared with traditional DAPT for 12 months. In interventions for valvular disease and heart failure: Evolut-in-Evolut redo-TAVI vs SAPIEN 3-in-Evolut redo-TAVI; TAVI in extra-small aortic annuli; the DurAVR transcatheter heart valve; transcatheter tricuspid valve intervention with the Mistral device; and more.

Debate

In-hospital initiation of PCSK9 inhibitors in ACS: pros and cons
Krychtiuk KA, Claeys M, Gencer B, Mach F
10.4244/EIJ-E-23-00014
free

Coronary interventions

Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial
Bär S, Kavaliauskaite R, Otsuka T, Ueki Y, Häner JD, Siontis G, Stortecky S, Shibutani H, Temperli F, Kaiser C, Iglesias JF, Jan van Geuns R, Daemen J, Spirk D, Engstrøm T, Lang I, Windecker S, Koskinas K, Losdat S, Räber L
10.4244/EIJ-D-23-00201
Stepwise provisional versus systematic culotte for stenting of true coronary bifurcation lesions: five-year follow-up of the multicentre randomised EBC TWO Trial
Arunothayaraj S, Behan M, Lefèvre T, Lassen JF, Chieffo A, Stankovic G, Burzotta F, Pan M, Ferenc M, Hovasse T, Spence M, Brunel P, Cotton J, Cockburn J, Carrié D, Baumbach A, Maeng M, Louvard Y, Hildick-Smith D
10.4244/EIJ-D-23-00211
Posterior pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: a systematic review and meta-analysis of 25 randomised controlled trials
Abdelaziz A, Hafez A, Elaraby A, Roshdy MR, Abdelaziz M, Eltobgy M, Elsayed H, El-Samahy M, Elbehbeh NA, Philip KG, Abdelaty AM, Rizk MA, Al-Tawil M, AboElfarh HE, Ramadan A, Ghaith H, Wahsh E, Abdelazeem B, Fayed B
10.4244/EIJ-D-22-00948

Editorial comment

Posterior pericardiotomy: “omnia cum tempore” (everything in its time)
Fremes S, Soletti G, Gaudino M
10.4244/EIJ-E-23-00018
free
Clinical performance of a novel hybrid IVUS-OCT system: a multicentre, randomised, non-inferiority trial (PANOVISION)
Jia H, Zhao C, Yu H, Wang Z, Liu H, Xu M, Hu S, Li L, He L, Weng Z, Qin Y, Xu Y, Zeng M, Su X, Liu B, Hou J, Yu B
10.4244/EIJ-D-22-01058
Aspiration technique in occlusive spontaneous coronary artery dissection
Spînu R, Belle L, Bonnet M, Cassar E, Mangin L
10.4244/EIJ-D-22-01055
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial
Guimarães PO, Franken M, Tavares CAM, Silveira FS, Antunes MO, Bergo RR, Joaquim RM, Hirai JC, Andrade PB, Pitta FG, Mariani Jr. J, Nascimento BR, de Paula JE, Silveira MS, Costa TA, Dall’Orto FT, Serpa RG, Sampaio FB, Ohe LN, Mangione FM, Furtado RH, Sarmento-Leite R, Monfardini F, Assis SR, Nicolau JC, Sposito AC, Lopes RD, Onuma Y, Valgimigli M, Angiolillo D, Serruys PW, Berwanger O, Bacal F, Lemos PA
10.4244/EIJ-D-23-00125

Interventions for valvular disease and heart failure

Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy
Grubb KJ, Shekiladze N, Spencer J, Perdoncin E, Tang GH, Xie J, Lisko J, Sanchez J, Lucas LM, Sathananthan J, Rogers T, Deeb GM, Fukuhara S, Blanke P, Leipsic J, Forrest JK, Reardon MJ, Gleason P
10.4244/EIJ-D-22-01125

Editorial comment

Being prepared for redo-TAVI in self-expanding Evolut valves – important insights
De Backer O, Montarello N, Sondergaard L
10.4244/EIJ-E-23-00024
free
Transcatheter aortic valve implantation in patients with extra-small aortic annuli
Tirado-Conte G, Rodés-Cabau J, Oteo J, Pan M, Muñoz E, Witberg G, Cheema A, Alperi A, Lopez D, Amat-Santos I, Akodad M, Ojeda S, Serra V, Garcia-Blas S, Alfonso F, De Backer O, Asmarats L, Muñoz A, Hamdan A, Toggweiler S, del Valle R, Salido L, Cruz-González I, Estevez-Loureiro R, Martin Alfaro LE, Gheorghe L, Dabrowski M, Berenguer A, Arzamendi D, Saia F, Webb JG, Sondergaard L, Nombela Franco L
10.4244/EIJ-D-23-00011
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve - DurAVR
Kodali SK, Sorajja P, Meduri CU, Feldt K, Cavalcante JL, Garg P, Hamid N, Poon KK, Settergren MR, Burns MR, Rück A, Sathananthan J, Zajarias A, Shaburishvili T, Zirakashvili T, Zhividze M, Katchakhidze G, Bapat VN
10.4244/EIJ-D-23-00282
One-year outcomes of transcatheter tricuspid valve repair with the Mistral device
Piayda K, Bertog S, Steffan J, Ilioska-Damköhler P, Beeri R, Sievert K, Sievert H, Yaron I, Danenberg H
10.4244/EIJ-D-22-01032

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved